Eli Lilly and Company: 10-K Risk Factor Changes

2024 vs 2023  ·  SEC EDGAR  ·  2026-10-16
Other years: 2026 vs 2025 · 2025 vs 2024
⚠ AI Risk Brief Interpretation layer — deterministic data below

Lilly added AI risk disclosure and removed pandemic language, reflecting evolving operational threat landscape.

Direction ↑ More concerning
✓ Deterministic extraction — no AI-generated data

Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.

1
New Risks
1
Removed
14
Modified
1
Unchanged
🟢 New in Current Filing Disclosure change10/10

•Our use of artificial intelligence (AI) or other emerging technologies could adversely impact our business and financial results.

🔴 No Match in Current Filing •Public health outbreaks, epidemics, or pandemics, such as the COVID-19 pandemic, have adversely impacted and may in the future adversely impact our business and operations. 🔒
🟡 Modified •Failure, inadequacy, breach of, or unauthorized access to, our IT systems or those of our third-party service providers, unauthorized access to our confidential information, or violations of data protection laws, could each result in material harm to our business and reputation. 🔒
🟡 Modified •Manufacturing, quality, or supply chain difficulties, disruptions, or shortages could lead to product supply problems. 🔒

And 12 more changes in the full comparison.

15 changes in this historical filing

The complete historical comparison (2024 vs 2023) is available on the Pro plan.

Get Pro access Already a Pro subscriber? View full diff →